{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "Amount",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P07288",
      "entity_text" : "PSA",
      "entity_type" : "protein"
    },
    "hypothesis_information" : false,
    "context" : {
      "Species" : [ "taxonomy:9606" ],
      "TissueType" : [ "tissuelist:TS-1224" ]
    }
  },
  "verbose_text" : "For almost 30 years, the decision to biopsy a patient has relied upon elevated prostate specific antigen (PSA) levels (generally greater than 4 ng/mL, though age specific PSA thresholds are commonly utilized) or abnormal findings on a digital rectal exam (DRE).",
  "reading_complete" : "2020-08-04T14:33:07Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T14:32:16Z",
  "trigger" : "levels",
  "evidence" : [ "PSA) levels" ],
  "pmc_id" : "6178315",
  "score" : 0
}